Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

GREY:CLAZF - Post Discussion

View:
Post by dayxday on Apr 18, 2021 3:38pm

SCOTTY

i am just waiting for this to happen to you guys! just a reminder.

https://www.investmentexecutive.com/newspaper_/news-newspaper/anonymous-comments-prove-costly/
Comment by WORKINMONTANA on Apr 18, 2021 4:01pm
Are you that retarded looking real estate agent from Oakville that their wife bangs the neighbour when you are at work? 
Comment by Dude51 on Apr 18, 2021 5:10pm
Scotty we are not the one who called this stock a shell company made disparaging comments about management. You also insinuate where's the money coming from like something nefarious is going on. How does it feel to be bashed? I think you owe us the investors an apology for being a dickwad with your comments. You certainly were not helping and may have caused weak hand to fold, that’s the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities